Category: Boehringer Ingelheim

How immunosuppression and secondary pathogens increase aMPV threat to US poultry

The emergence of aMPV subtypes A and B has left US poultry producers seeking new tools to reduce the economic impact of this disease. In an interview, Silke Rautenschlein, PhD, professor at the University of Veterinary Medicine in Hannover, Germany, covers the past, present and future of the virus and its control.  

More from Boehringer Ingelheim

Modern Poultry is pleased to host
this editorial page on behalf of

Boehringer Ingelheim
Animal Health